03 September 2021>: Articles
Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?
Unusual clinical course, Unusual or unexpected effect of treatment, Unexpected drug reaction
Khezar Syed A* , Haseeb Chaudhary A , Anthony Donato EDOI: 10.12659/AJCR.933397
Am J Case Rep 2021; 22:e933397
Table 1. Lab work and thrombophilia work-up.
Hemoglobin | 15.7 g/dL | PT | 14.8 sec (11.7–14.2 sec) |
WBC | 17.9×10E3/uL | INR | 1.2 |
Platelets | 255×10E3/uL | APTT | 30.5 sec (23.1–34.3 sec) |
Sodium | 142 | Potassium | 3.9 |
HCO3 | 7.1 | Chloride | 99 |
Creatinine | 134.4 umol/L (1.52 mg/dL) | BUN | 8.93 mmol/L (25 mg/dL) |
Magnesium | 2.9 | Calcium | 10.2 |
Glucose | 19.25 mmol/L (347 mg/dL) | Lactic Acid | 28.3 mmol/L |
COVID-19 RT-PCR | Negative | Troponin | |
Rheumatoid factor | Myeloperoxidase ab | 0 (0–19 AU/mL) | |
Factor V Leiden (F5) R506Q Mutation | Negative | Anti-nuclear antibodies | Negative |
ANA, Hep-2 Antibody IgG | Angiotensin Converting enzyme | 32 (9–67 U/L) | |
Cardiolipin IgA, IgM, IgG | Negative | Lipoprotein A | 32 (≤29 mg/dL) |
Prothrombin (F2) G20210A Mutation | Not detected | Anti-neutrophil cytoplasmic antibody IgG | |
Serine Proteinase 3 AB IgG | 0 (0–19 AU/mL) |